Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 462 shares at $225.27 ($104K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
Open-market sale of $104k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.23 | 74 | $17K | 15.9% |
| 2 | $224.04 | 161 | $36K | 34.7% |
| 3 | $225.27 | 111 | $25K | 24.1% |
| 4 | $226.15 | 116 | $26K | 25.3% |
| Total | $224.74 avg | 462 | $104K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |